Smoothing out our path to open source and pan-pharma code collaboration

In recent years late stage Pharma has begun to transition from a consumer of open source, and a sporadic creator, to a heavily invested collaborator on open source tools like R packages. In this short talk, James will discuss our recent focus on open source collaboration in post-competitive tools, and some important lessons we’ve learned.